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contributes to the regulation of osteoclast structure but not 
to bone metabolism in vivo.
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Introduction
Bone remodeling is a dynamic, life-long process in which 
bone formation by osteoblasts and bone resorption by oste-
oclasts are balanced to maintain a steady state. Osteoclasts 
are multinucleated resorptive cells of bone [1] that contrib-
ute to the maintenance of bone homeostasis. Osteoclasts 
are formed by fusion of monocyte/macrophage lineage pre-
cursor cells under the control of macrophage colony stimu-
lating factor (M-CSF), which regulates the survival and 
proliferation of precursors [2], and by receptor activator of 
nuclear factor-kappa B ligand (RANKL), which promotes 
osteoclast differentiation and bone resorptive activity [3–5].
During osteoclastogenesis, the tight control of actin 
filament organization is crucial for cell formation, fusion, 
and differentiation and for cell attachment to bone sur-
faces. Notably, there are two structures in osteoclasts that 
are enriched with actin filaments: podosomes and sealing 
zones [6]. In early stages of osteoclastogenesis, podosomes 
are organized as clusters, which associate into actin rings 
that eventually form belts at the osteoclast periphery. Seal-
ing zones form when osteoclasts adhere to mineralized 
bone surfaces, after which bone resorption is initiated [6, 
7]. The organization and maintenance of these structures in 
osteoclasts is very dependent on the appropriate formation 
of actin filaments, which in turn requires temporally and 
spatially appropriate activities of actin-binding proteins.
Abstract Adseverin is an actin-severing/capping protein 
that may contribute to osteoclast differentiation in  vitro 
but its role in bone remodeling of healthy animals is not 
defined. We analyzed bone and osteoclast structure in 
adseverin conditional null mice at alveolar and long bone 
sites. In wild-type and adseverin null mice, as measured 
by dual-energy X-ray absorptiometry, there were no dif-
ferences of bone mineral content or bone mineral den-
sity, indicating no change of bone metabolism. In tibiae, 
 TRAcP+ osteoclasts were formed in comparable num-
bers in adseverin null and wild-type mice. Ultrastructural 
analysis showed normal and similar abundance of ruffled 
borders, sealing zones, and mitochondria, and with no dif-
ference of osteoclast nuclear numbers. In contrast, analyses 
of long bone showed that in the absence of adseverin osteo-
clasts were smaller (120 ± 13 vs. 274 ± 19 µm2; p < 0.05), 
as were nuclear size and the surface area of cytoplasm. 
The nuclei of adseverin null osteoclasts exhibited more 
heterochromatin (31 ± 3%) than wild-type cells (8 ± 1%), 
suggesting that adseverin affects cell differentiation. The 
data indicate that in healthy, developing tissues, adseverin 
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There are hundreds of actin-binding proteins, which 
include the gelsolin family of actin-severing and actin-cap-
ping proteins that contribute to actin filament remodeling 
in a calcium-dependent manner [8, 9]. Gelsolin is involved 
in osteoclast function since compared to wild type, gelso-
lin-deficient mice exhibit increased bone mass and bone 
strength and defective podosome assembly in osteoclasts 
[10]. During osteoclastogenesis, gelsolin expression levels 
are relatively constant, while in cultured cells the expres-
sion of the gelsolin family protein adseverin is dramatically 
increased [11]. More recent data indicate that adseverin is 
important in osteoclastogenesis and may be an essential 
regulator of osteoclastic activity [11–13].
Adseverin (also known as scinderin) is an actin-sever-
ing/capping protein that has been studied in depth in chro-
maffin cells of the adrenal medulla [14]. The severing func-
tion of adseverin helps control actin filament length, while 
the actin-capping function of adseverin stabilizes actin 
filaments. Adseverin is highly expressed in many types of 
secretory cells, platelets [15], chondrocytes [16], odonto-
blasts [17], and differentiating osteoclasts [18]. Adseverin 
stimulates osteoclast differentiation and cell–cell fusion in 
cultured cells; the expression of adseverin is also increased 
in RANKL-induced osteoclastogenesis [11–13]. Adseverin 
knockdown inhibits bone resorption, reduces the secretion 
of TRAcP and cathepsin K, and alters actin filament organ-
ization [11, 13]. The increased expression of adseverin 
in osteoclastogenesis is dependent on the nuclear factor-
kappa B (NF-κB) signaling pathway and on the expression 
of the osteoclastogenic transcription factor NFATc1 [13]. 
Adseverin co-localizes with actin filaments in podosomes; 
in adseverin knockout mice, osteoclasts exhibit lower num-
ber of podosome belts [12]. While these data suggest an 
important role for adseverin in osteoclastogenesis in vitro, 
it is not known whether adseverin impacts bone structure in 
healthy animals.
Here we examined bones from adseverin conditional 
null mice and background-matched wild-type mice by light 
microscopy, dual-energy X-ray absorptiometry (DEXA), 
and transmission electron microscopy (TEM). Since osteo-
clast function may differ in different skeletal sites [19–21], 
we compared osteoclast structure in alveolar bone with 
long bone and in healthy and inflamed sites.
Methods and Materials
Adseverin Knockout Mouse Model
All animal experiments were carried out in accordance 
with the Guide for the Humane Use and Care of Laboratory 
Animals and were approved by the University of Toronto 
Animal Care Committee. The generation of adseverin 
conditional knockout (adseverin KO) mice is described 
elsewhere [12]. In brief, mice harboring the conditional 
allele of adseverin were obtained by creation of a target-
ing vector that interrupted the expression of adseverin. 
After introduction of the targeting construct, LoxP floxed 
adseverin C57BL/6 mice were crossed with TRAcP-Cre 
C57 mice (from Christine M. Hachfeld, Mayo Clinic, Roch-
ester, MN). The male mice generated by this breeding were 
further back-crossed with the pure LoxP floxed adseverin 
females. Littermates that did not express TRAcP-Cre are 
designated here as wild type (WT). The effectiveness of the 
knockout was confirmed by expression of TRAcP-Cre and 
LoxP by PCR. The primers that were used to genotype the 
adseverin mice were as follows: Cre expression: Forward: 
5′-GAG TGA TGA GGT TCG CAA GA-3′; Reverse: 5′-CTA 
CAC CAG AGA CGG AAA TC-3′; Product size: 635  bp. 
Distal LoxP: SCAD3: 5′-GTT AGT ATT CCT CAC TGG 
CACCC-3′; Ads-SDL2: 5′ ATG TTT CAG GAC AGG AGT 
CTG AGC -3′; Presence of the distal LoxP: 363  bp; Wild-
type adseverin allele: 289  bp. Around the left upper first 
molar, inflammation was induced by bacteria ligature in 
both WT and adseverin KO mice to compare the phenotype 
of that in the right part of the same mouse.
Dual‑Energy X‑ray Absorptiometry
DEXA was performed on 3-month-old mice after  CO2 
asphyxiation, using an animal PIXImus densitometer 
(Lunar; GE). Data for bone mineral density (BMD) and 
bone mineral content (BMC) were collected for the lumbar 
vertebrae, right femur, and the entire skeleton after mask-
ing of the heads by a single operator.
TRAcP Staining and Image Analysis
Distal tibia were removed, fixed with 4% paraformaldehyde 
(PFA), and decalcified in 10% EDTA (pH 7.4) at 4 °C for 2 
weeks. After dehydration, the samples were embedded in 
paraffin and sectioned (5  µm thick). TRAcP staining was 
performed to assess the presence of osteoclasts. Osteoclasts 
were visualized with a Nikon Eclipse E1000 microscope 
and images were obtained with a Hamamatsu ORCA-ER 
camera and processed using Simple PCI software (Version 
5.2.1.1609; Compix Inc). Osteoclasts were recognized as 
 TRAcP+ cells and the number of osteoclasts was counted 
relative to the bone surface, according to standardized 
histomorphometric methods [22].
Transmission Electron Microscopy
At 2 months of age, WT and adseverin KO mice were 
sacrificed. Mice were perfused with fixative (1% glutar-
aldehyde + 4% formaldehyde in 0.1  M sodium cacodylate 
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buffer). Maxillae and long bones were collected and fixed in 
the same fixative. After decalcification in EDTA (pH = 7.2) 
for 14 days at room temperature, specimens were post-fixed 
with 1%  OsO4 for 1 h. After subsequent washing in buffer, 
samples were dehydrated by an ethanol series. Specimens 
were embedded in epoxy resin (LX112). Resin-embedded 
specimens were trimmed and 1-µm thin sections were cut. 
Sections were stained with Richardson’s solution for light 
microscopic analysis (Leica DMRA). Image-Pro plus soft-
ware (Media Cybernetics, Silver Spring, MD) was used to 
assess the size of osteoclasts.
After examining the sections by light microscopy, sites 
of interest were selected and ultrathin sections (80  nm) 
were cut with a diamond knife. The ultrathin sections were 
collected on Formvar-coated copper grids and counter-
stained with uranyl acetate and lead citrate. Micrographs 
were obtained with a Philips CM10 electron microscope. 
Size measurement of osteoclasts/nuclei/cytoplasm area was 
assessed by Image-Pro plus software (Media Cybernetics, 
Silver Spring, MD). Osteoclasts with ≥1 nucleus were used 
for analysis. Stereological analysis was performed accord-
ing to Weibel et al. [23].
Statistical Analysis
Results were shown as mean ± SD. Each experiment had a 
sample size of n ≥ 3, unless otherwise stated. Mean of the 
measurements of each osteoclast/nuclei/cytoplasm was 
calculated per mouse and pooled to compare the differ-
ence between WT and adseverin KO. Statistical analysis 
was performed using GraphPad Prism (version 5.0; Graph-
Pad Software, LaJolla, CA). Student’s t test was used to 
compare the data between WT and KO. Statistical signifi-
cance was set at p < 0.05.
Results
Osteoclast Number and Bone Resorption
The effectiveness of conditional knockout of adseverin was 
confirmed by PCR (Fig. 1a). The role of adseverin in bone 
resorption in vivo is not well defined: previous micro-CT 
data showed no difference of bone structure between nor-
mal WT and adseverin KO mice [12], while in the same 
study adseverin null mice were protected from inflamma-
tion-mediated bone loss. To determine whether osteoclasts 
and their resorptive activity are dependent on adseverin, 
we analyzed  TRAcP+ osteoclasts in long bones of WT and 
adseverin KO mice (Fig.  1c, d). The number of  TRAcP+ 
osteoclasts per bone surface was not different between the 
two genotypes (Fig. 1b). DEXA analysis showed no differ-
ence of bone mineral density or bone mineral content of the 
whole body, vertebrae, or femurs between adseverin KO 
and WT mice at 3 months of age (Table 1). These data indi-




Osteoclasts on the surface of the alveolar bone proper, 
and those located adjacent to the periodontal ligament, 
Fig. 1  The number of osteo-
clasts in vivo was not changed 
by knocking out adseverin. a 
Mice were genotyped using 
PCR to test the effectiveness 
by determining TRAcP-Cre 
(635 bp), distal floxed Ads 
product (363 bp) as well as 
wild-type mouse Ads ampli-
con (289 bp). b No significant 
difference of osteoclast number 
per bone surface was found 
(p = 0.7441). c, d TRAcP-
stained sections of distal tibiae 
were analyzed and  TRAcP+ 
cells (arrow) were shown in 
WT (c) and adseverin KO (d) 
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exhibited multiple nuclei and numerous mitochondria 
(Fig.  2). These features were similar for WT (Fig.  2a, c) 
and adseverin KO mice (Fig.  2b, d). In some samples in 
which silk ligatures were wrapped around the circumfer-
ence of molar teeth to induce gingival inflammation, there 
were osteoclasts on the surface of the adjacent alveolar 
bone but there were no obvious differences of osteoclast 
structure between genotypes (Fig.  2c, d). Although there 
were abundant large osteoclasts on bone surfaces adjacent 
to inflamed gingival tissues, because of the low number 
of osteoclasts, we could not conduct meaningful statistical 
analysis of cell size.
Long Bone
We found large numbers of osteoclasts on bone and calci-
fied cartilage surfaces adjacent to the growth plate of tibiae 
in WT and KO mice (Fig. 3a–d; see also Fig. 1). Most oste-
oclasts were found at the junction of the growth plate carti-
lage and trabecular bone and were always in close vicinity 
to blood vessel capillaries. There were no obvious ultras-
tructural differences between osteoclasts from WT mice 
and KO mice (Fig. 3e, f). Osteoclasts in WT and adseverin 
KO mice were tightly adherent to the bone surface and 
exhibited well-developed sealing zones and ruffled borders.
Table 1  DEXA analysis of 
BMC and BMD of WT and 
adseverin KO mice
No significant difference was found between WT and adseverin KO mice by DEXA analysis
Bone mineral content (BMC) and bone mineral density (BMD) were collected from the lumbar vertebrae, 
right femur, and the entire skeleton after masking of the heads
p values were calculated by t tests and data were shown as mean ± SD
p < 0.05 was considered statistically significant
Samples Parameters WT Adseverin KO p value
3 months old (n = 6) Whole body BMC (g) 0.391 ± 0.010 0.338 ± 0.020 0.060
Whole body BMD (g/cm2) 0.060 ± 0.002 0.056 ± 0.001 0.069
Vertebrae BMC (g) 0.053 ± 0.001 0.044 ± 0.006 0.163
Vertebrae BMD (g/cm2) 0.060 ± 0.001 0.054 ± 0.004 0.261
Femur BMC (g) 0.017 ± 0.001 0.016 ± 0.001 0.776
Femur BMD (g/cm2) 0.066 ± 0.003 0.066 ± 0.003 0.877
Fig. 2  Morphology of 
osteoclasts in molar. Osteoclasts 
adjacent to the alveolar bone of 
molars were visualized by TEM 
and compared between WT and 
adseverin KO mice. a Normal 
condition (without ligature) in 
WT mice. b Normal condition 
in adseverin KO mice. c Inflam-
matory condition (induced 
with ligature around molar) 
in WT mice. d Inflammatory 
condition in adseverin KO mice. 
Osteoclasts are encircled with 
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Ruffled Borders
As adseverin may be important for podosome structure 
and bone resorption in  vitro [12], we examined ruffled 
borders in detail. Ruffled borders were well developed in 
osteoclasts of both genotypes and were readily apparent 
in alveolar bone (Fig.  4a–d) and long bone (Fig.  4e, f) 
of WT and KO mice. There were no obvious morpho-
logical differences between the genotypes. Experimen-
tally induced inflammation did not affect the formation 
of ruffled borders in WT (Fig. 4c) or adseverin KO mice 
(Fig.  4d). At healthy and inflamed sites, ruffled borders 
exhibited long, finger-like extensions (about 2  µm long, 
100–200  nm wide) and were enriched with vacuoles 
that are important in exocytosis and endocytosis in bone 
resorption [24].
Sealing Zones
Sealing zones were prominent in osteoclasts of WT and 
adseverin KO mice (Fig.  5a, b). The numbers of osteo-
clasts associated with bone surface were not different 
between the two genotypes (p = 0.25), indicating that 
adseverin does not contribute to osteoclast attachment to 
bone.
Fig. 3  Morphology of 
osteoclasts in long bone. a–d 
Morphology of osteoclasts 
as observed by light micros-
copy. Relatively high numbers 
of osteoclasts were found in 
the growth plate area in both 
WT (a, c) and adseverin KO 
(b, d) mice. Arrows point to 
osteoclasts. Scale bar 20 µm. 
e, f Morphology of osteoclasts 
visualized by TEM. Scale bar 
5 µm. Osteoclasts are encircled 
with a dashed line. N nucleus, 
B bone, RB ruffled border, FSD 
functional secretory domain, 
OC osteoclast, CC chondrocyte, 
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Osteoclast Size
Previous in  vitro studies showed that osteoclasts gener-
ated from precursors derived from adseverin null mice 
were smaller [12]. In the present study, we analyzed 
the size of osteoclasts formed in  vivo and found that 
adseverin KO mice had significantly smaller osteoclasts 
(Fig.  6). Osteoclasts in WT mice were 274 ± 19  µm2, 
while osteoclasts in adseverin KO mice were less than 
half of this size (120 ± 13 µm2; p < 0.001; Fig. 6a). Since 
osteoclast size is affected by cell fusion processes, the 
number of nuclei per cell was assessed. There was no 
difference in the numbers of nuclei per cell (Fig.  6b), 
indicating that adseverin does not affect the fusion of 
osteoclast precursor cells in normal bone in  vivo. Fur-
ther, consistent with their smaller size, osteoclasts from 
adseverin null mice exhibited smaller cytoplasmic area 
(Fig. 6c).
Nuclear Size and Chromatin Distribution
Overall assessment of the shapes of osteoclast nuclei in 
adseverin KO mice indicated marked differences between 
KO and wild-type mice (Fig.  7a–d). Osteoclast nuclei in 
WT mice were predominantly round or oval shaped with 
a smooth, nuclear membrane surface (Fig. 7a, c), while the 
nuclei of osteoclasts in adseverin KO mice exhibited prom-
inent folds and indentations (Fig. 7b, d).
The spatial distributions of euchromatin and hetero-
chromatin were affected by adseverin expression. The 
amount of heterochromatin, which is a tightly packed, 
electron-dense, transcriptionally inactive chromatin, was 
fourfold more abundant in osteoclast nuclei of adseverin 
KO mice (31 ± 3%) than WT mice (8 ± 1%) (Fig.  7e). 
Euchromatin, which is an electron-lucent, loosely packed 
Fig. 4  Osteoclasts of adseverin 
KO mice form a normal ruffled 
border. a Ruffled border of an 
osteoclast from molar in control 
condition in WT. b Ruffled bor-
der of an osteoclast from molar 
in control condition in adseverin 
KO mice. c Ruffled border of an 
osteoclast from molar in inflam-
matory condition in WT mice. d 
Ruffled border of an osteoclast 
from molar in inflammatory 
condition in adseverin KO mice. 
e Ruffled border of an osteo-
clast from long bone in WT. f 
Ruffled border of an osteoclast 
from long bone in adseverin KO 
mice. Arrows point to the ruffled 
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Fig. 5  Adseverin knockout did 
neither affect the attachment 
nor the formation of sealing 
zone in vivo. a, b. Sealing zone 
structure in WT mice (a) and 
adseverin KO mice (b). c There 
was no significant difference of 
the attachment between WT and 
adseverin KO mice. SZ sealing 






























Fig. 6  The size of osteoclasts 
and cytoplasm surface area 
were significantly decreased 
in adseverin KO mice in long 
bone. a Comparison of the 
size of osteoclasts between 
WT and adseverin KO mice 
(***p < 0.001). b The number 
of nuclei per osteoclast was 
similar in adseverin KO mice. 
c Percentage of cytoplasm 
surface area was significantly 
reduced in adseverin KO mice 
(***p < 0.001). Assessment of 
size was performed by Image-
Pro Plus and the number of 
osteoclasts analyzed for the size 
was 63 for WT, and 134 for 
adseverin KO; for # cytoplasm 
surface area 32 for WT and 
42 for adseverin KO. d, e An 
example of an osteoclast in WT 
(d) and adseverin KO (e) mice. 
Osteoclasts are encircled by a 
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transcriptionally active chromatin, showed the opposite dis-
tribution (Fig. 7f). Examination of nuclear size showed that 
osteoclast nuclei in adseverin KO mice were smaller than 
osteoclast nuclei in WT mice (Fig. 7g).
Discussion
Our findings indicate that the actin-capping/severing pro-
tein adseverin contributes to the maintenance of osteoclast 
size and nuclear chromatin organization. In the absence of 
adseverin expression, osteoclasts were smaller, and with 
reduced cytoplasmic area and nuclear size, suggesting that 
osteoclast structure is affected by adseverin-dependent 
regulation of the actin filament network. Indeed, previous 
studies indicated that actin filaments could control the vol-
ume [25] and growth of cells [26]. The actin cytoskeleton 
is a dynamic system that may serve as an interactive sen-
sor in cell volume regulation to maintain actin filaments 
in equilibrium [27]. Actin filament organization may 
be linked to the extent of cell swelling, by either regula-
tion of ion transport systems or interactions of actin-asso-
ciated proteins with discrete plasma membrane domains 
[28]. Cantiello and colleagues suggested that interactions 
between actin and actin-severing/capping proteins influ-
ence the activity of  Na+/K+ channels, which regulate the 
movement of water and affect cell volume [29]. We pro-
pose that when adseverin is not expressed, the organization 
of actin cytoskeletal structures is affected, which in turn 
affects osteoclast size but, remarkably, not podosome struc-
ture. Evidently, the stability and turnover of actin filament 
structures in osteoclasts is under the control of multiple 
regulatory systems, one of which is adseverin.
The reduced size of osteoclasts in  vivo in adseverin 
KO mice is consistent with previous in  vitro studies 
showing that osteoclasts generated from precursor cells 
obtained from adseverin null mice were smaller [11, 12]. 
The smaller size of these osteoclasts was considered to 
Fig. 7  Nuclei of osteoclasts 
in adseverin knockout mice 
contained more heterochromatin 
and were smaller. a–d Nuclei 
of osteoclasts in WT (a, c) and 
adseverin KO mice (b, d). a, b 
Scale bar 5 µm; c, d scale bar 
2 µm. e Percentage of hetero-
chromatin was significantly 
higher in nuclei from adseverin 
KO mice. f Percentage of 
euchromatin was significantly 
lower in nuclei from adseverin 
KO mice. g The size of 
nuclei proved to be smaller in 
adseverin KO mice. Assess-
ment of size was performed by 
Image-Pro Plus and the number 
of nuclei analyzed was 52 for 
WT and 67 for adseverin KO. E 
euchromatin, H heterochroma-
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be a result of the impaired fusion capacity of osteoclast 
precursors. Our current data show that the number of 
nuclei per osteoclast did not differ between adseverin null 
and wild-type littermates, indicating that fusion was not 
affected in vivo.
Although actin is one of the most abundant proteins in 
the cytoplasm, new data show a role for nuclear actin in 
cell function and structure [30–32]. While adseverin has 
not been demonstrated in the nucleus, gelsolin [31] and 
the actin-capping protein CapG [33] have been reported in 
the nucleus. Actin is present in cells in globular (G-actin), 
oligomeric, or filamentous form. In the nucleus, actin is 
mainly found as G-actin or oligomers [34], which requires 
the action of severing proteins like gelsolin to gener-
ate short oligomers or monomers. Nuclear actin assem-
bly can affect transcription [35], suggesting an important 
relationship between the organization of actin filaments 
and transcriptional regulation. Consistent with this notion, 
we found that in the absence of adseverin the packing of 
heterochromatin was increased. Since heterochromatin is 
thought to be transcriptionally inactive because of a high 
proportion of repetitious sequences [36, 37], adseverin may 
regulate transcription and potentially histone assembly, 
which is reflected in chromatin packing. Adseverin, possi-
bly in combination with actin, may play a previously unrec-
ognized role in the organization of chromatin in osteoclast 
nuclei.
One of the most prominent sites of actin cytoskeletal 
organization in the osteoclast is at the sealing zone, where 
cells are firmly attached to the bone surface, which is a 
prerequisite for efficient bone degradation [7]. While pre-
vious in vitro studies showed that adseverin affects podo-
some self-organization [12], we found no differences in the 
structure of sealing zones of osteoclasts between WT and 
adseverin KO mice. Further, osteoclasts in adseverin KO 
mice formed a normal ruffled border and with no effect on 
bone resorption compared with WT mice. These data are 
in agreement with a previous study in which micro-CT 
showed an unchanged bone phenotype in healthy adseverin 
KO mice [12]. We analyzed osteoclasts at different skeletal 
sites and compared normal bone with bone adjacent to sites 
with induced inflammation. The structure and function of 
osteoclasts from different skeletal sites can be quite differ-
ent [19]. In vitro studies showed that osteoclasts generated 
from precursors derived from alveolar bone and from long 
bone exhibit marked differences in cell shape [20]. Here 
we found no measureable differences in osteoclasts at long 
bone and alveolar bone sites in WT and adseverin null con-
ditional mice. Further studies are needed to elucidate this 
difference between in vitro and in vivo works.
Collectively, our findings indicate that although the 
actin-severing/capping protein, adseverin, does not con-
tribute to bone metabolism in vivo, it plays an important 
role in the control of osteoclast size and in the organiza-
tion of chromatin structure and nuclear size.
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